The Rodriguez Translational Therapeutics Lab seeks to translate our understanding of the brain bases of emotion and behavior to develop rapid-acting treatments for mental illness. We partner with collaborators at multiple points long the drug discovery and development pathway, and we seek to discover new treatments across the lifespan.
Our interdisciplinary approach involves identifying promising compounds and designing clinical trials that simultaneously provide information about mechanism and efficacy. We utilize multiple modalities (fMRI, EEG, MRS) to understand where and when compounds are targeting the brain (from molecule to circuit, to networks to behavior) to produce rapid relief of symptoms.
We are committed to educating the public about mental illness and clinical research.